{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:07:18Z","timestamp":1779228438461,"version":"3.51.4"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004828","name":"Grand Challenges Canada","doi-asserted-by":"publisher","award":["0167-03"],"award-info":[{"award-number":["0167-03"]}],"id":[{"id":"10.13039\/501100004828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Neonatal sepsis is a major cause of infant mortality in developing countries because of delayed injectable treatment, making it urgent to develop noninjectable formulations that can reduce treatment delays in resource-limited settings. Ceftriaxone, available only for injection, needs absorption enhancers to achieve adequate bioavailability via nonparenteral administration.<\/jats:p>","DOI":"10.1128\/aac.01170-18","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T14:31:52Z","timestamp":1538749912000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions"],"prefix":"10.1128","volume":"62","author":[{"given":"Boubakar","family":"Ba","sequence":"first","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Gaudin","sequence":"additional","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"D\u00e9sir\u00e9","sequence":"additional","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thida","family":"Phoeung","sequence":"additional","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Langlois","sequence":"additional","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charan R.","family":"Behl","sequence":"additional","affiliation":[{"name":"Hoffmann-La Roche Inc., Little Falls, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Unowsky","sequence":"additional","affiliation":[{"name":"Hoffmann-La Roche Inc., Little Falls, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indravadan H.","family":"Patel","sequence":"additional","affiliation":[{"name":"Hoffmann-La Roche Inc., Little Falls, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Waseem","family":"Malick","sequence":"additional","affiliation":[{"name":"Hoffmann-La Roche Inc., Little Falls, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melba","family":"Gomes","sequence":"additional","affiliation":[{"name":"Consultant, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"White","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-6684","authenticated-orcid":false,"given":"Tina","family":"Kauss","sequence":"additional","affiliation":[{"name":"EA 4575 Analytical and Pharmaceutical Developments Applied to Neglected Diseases and Counterfeits, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1441"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000692"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000163"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00474-2"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1985.tb03423.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1869-1871.2006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.2.159"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441782"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.2.191"},{"key":"e_1_3_2_11_2","article-title":"Testing breakpoint tables for interpretation of MICs and zone diameters","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2018","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2018. Testing breakpoint tables for interpretation of MICs and zone diameters. European Committee on Antimicrobial Susceptibility Testing.","journal-title":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"e_1_3_2_12_2","unstructured":"Theriaque. 2018. Theriaque French public medical database. www.theriaque.org. Accessed 23 July 2018."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-5428(03)30002-4"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.5897\/JBSB2013.0045"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198427060-00001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01037955"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.5.634"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.90"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611010-00005"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.2.248"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.82"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069712"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238551"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10563"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0932-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000457016"},{"key":"e_1_3_2_27_2","first-page":"3","article-title":"In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review","volume":"17","author":"Bijie H","year":"2005","unstructured":"Bijie H, Kulpradist S, Manalaysay M, Soebandrio A. 2005. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review. J Chemother 17:3\u201324.","journal-title":"J Chemother"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322011000700024"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(03)00065-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00029-8"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg482"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki079"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.04.010"},{"key":"e_1_3_2_34_2","unstructured":"ICH. ICH quality guidelines; Q1A-Q1F stability. ICH Geneva Switzerland. http:\/\/www.ich.org\/products\/guidelines\/quality\/article\/quality-guidelines.html. Accessed 21 September 2018."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81142-1"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200301306"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01170-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01170-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:14:39Z","timestamp":1645478079000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01170-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1128\/AAC.01170-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01170-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2018-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01170-18"}}